This role involves leading epidemiology programs, designing and delivering observational studies using real-world data, and providing scientific advice to asset teams. The position requires a master’s degree in a quantitative field and at least 5 years of applied epidemiology experience.
This role involves leading epidemiology programs, designing and delivering observational studies using real-world data, and providing scientific advice to cross-functional teams. The position offers opportunities for growth and impact in a hybrid working environment.
Leads global respiratory epidemiology and real-world evidence initiatives to inform vaccine development, designing studies on disease burden, treatment patterns, and safety. Works cross-functionally with clinical, regulatory, and safety teams, manages external collaborations, and drives scientific dissemination through publications and regulatory submissions. Focuses on strategic epidemiological planning and mentoring junior staff in a matrixed environment.
Leads global respiratory epidemiology and real-world evidence initiatives to shape vaccine development, designing and delivering studies on disease burden, treatment patterns, and safety. Works cross-functionally with clinical, regulatory, and external partners, driving scientific strategy and innovation. Involves mentoring staff, managing collaborations, and disseminating findings through publications and regulatory submissions.
Leads the design and execution of real-world evidence (RWE) and health outcomes studies to support oncology assets across the product lifecycle. Translates customer and payer needs into robust scientific evidence, collaborating with cross-functional teams to inform market access, reimbursement, and value-based pricing strategies. Focuses on generating high-quality, decision-ready data using diverse real-world data sources and advanced study methodologies.
Leads the design and execution of real-world evidence (RWE) and health outcomes studies to support oncology assets across their lifecycle. Focuses on generating robust, scientifically credible data to inform value propositions, market access, and reimbursement strategies. Collaborates with cross-functional teams and external experts to align evidence generation with payer, clinician, and regulatory requirements.
This role leads the global development of a medicine from clinical proof of concept to first-market approval, serving as the single point of accountability within GSK's matrixed R&D environment. The VP Medicine Development Leader will build and lead a cross-functional team, define strategic development plans, and ensure alignment with regulatory, commercial, and manufacturing stakeholders. The position emphasizes evidence-based decision-making, lifecycle planning, and patient-focused development across multiple indications.
This role involves leading and executing strategic partnerships for Real World Data (RWD) to support GSK's R&D and commercial activities. Responsibilities include building and managing RWD partnerships, ensuring data access and analysis, and collaborating with internal and external stakeholders to maximize the value of RWD in decision-making and evidence generation.
This role involves leading the strategic execution of external data partnerships to enhance R&D and CPO activities. Responsibilities include defining and delivering RWD partnerships, maintaining data quality, and fostering relationships with academic institutions, health technology companies, and data holders to support regulatory approval and evidence generation.
Lead the design and execution of real-world evidence and health outcomes studies to support oncology assets, aligning scientific research with payer, clinician, and regulatory needs. Collaborate across medical, commercial, and R&D teams to generate robust data for value-based pricing and market access. Drive study planning, analysis, and dissemination while engaging external experts and shaping evidence strategies in a global context.
This role involves planning, designing, and executing multiple real-world evidence studies to support the launch and market positioning of GSK's oncology products. The Director will collaborate with internal and external stakeholders to ensure the evidence meets the needs of payers, health systems, and providers, and will manage timelines, deliverables, and budgets.
This role involves planning, designing, and executing multiple studies to support the launch and market positioning of GSK's oncology medicines. The Director will collaborate with internal and external stakeholders to generate robust real-world evidence and cost-effectiveness analyses, ensuring strategic alignment and effective communication.
Leads the design and execution of real-world evidence (RWE) and health outcomes studies to support oncology assets across the product lifecycle. Collaborates with cross-functional teams to generate robust data for regulatory, reimbursement, and market access decisions. Engages with internal stakeholders and external experts to align scientific research with payer and clinician needs, ensuring evidence impacts patient access and commercial success.
Lead the global development of a specialty medicine from clinical proof of concept to first-market approval, serving as the single point of accountability across a matrixed, cross-functional team. Define strategic vision, oversee clinical and regulatory planning, and make evidence-based go/no-go decisions. Engage with regulators, senior leadership, and external stakeholders to advance patient-focused drug development within GSK’s R&D strategy.
This role leads the global development of a specialty medicine from clinical proof of concept through to regulatory approval, serving as the single point of accountability. The VP will build and lead a cross-functional matrix team, define strategic development plans, make evidence-based go/no-go decisions, and ensure alignment with GSK's R&D and commercial strategies. The position involves significant interaction with regulators, senior management, and external stakeholders to deliver differentiated medicines and support lifecycle management.
